... said the initiatives were aimed at preventing Beijing from moving ahead with plans to develop global competitors in technologies including biotech ...
News
- Global stocks sink on trade worries, oil mixed
- Initial public offerings scheduled to debut next week
Business: Early-stage biotech developing mRNA therapies for genetic ... Business: Late-stage biotech targeting conditions associated with chronic ...
- SA researchers exploring use of re-purposed cancer drugs to combat deadly TB
Scientists at San Antonio's Texas Biomedical Research Institute are studying the effectiveness of promising experimental cancer chemotherapy drugs ...
- Assembly Biosciences (Call) (ASMB) Valuation Declined While Longwood Capital Partners ...
Assembly Biosciences, Inc. (NASDAQ:ASMB) has risen 70.43% since June 22, 2017 and is uptrending. It has outperformed by 57.86% the S&P500.
- Texas Biomed Slated for 10-Year Transformation as Challenges Loom
Texas Biomedical Research Institute in West San Antonio will retool over the next decade – doubling its faculty and redesigning its campus – to ...